Endothelial signaling and the molecular basis of arteriovenous malformation

Cellular and Molecular Life Sciences

Volumn 71, Issue 5, 2014, Pages 867-883

  Atri, Deepak ^a   Larrivée, Bruno ^a,b   Eichmann, Anne ^a,c   Simons, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MONTREAL   (Canada)

^c Centre de Recherche Interdisciplinaire en Biologie   (France)

Author keywords

ALK1; Arteriovenous malformation; DLL4; Endo MT; ENG; Notch; RASA1; TGF

Indexed keywords

EID: 84893825609     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1475-1     Document Type: Review

References (146)

1. Laakso A, Hernesniemi J (2012) Arteriovenous malformations: epidemiology and clinical presentation. Neurosurg Clin N Am 23(1):1-6. doi:10.1016/j.nec. 2011.09.012
2. Kim H, Sidney S, McCulloch CE, Poon KY, Singh V, Johnston SC, Ko NU, Achrol AS, Lawton MT, Higashida RT, Young WL (2007) Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke 38(9):2430-2437. doi:10.1161/STROKE AHA.107.485573
3. Ogilvy CS, Stieg PE, Awad I, Brown RD Jr, Kondziolka D, Rosenwasser R, Young WL, Hademenos G (2001) AHA scientific statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke 32(6):1458-1471
4. Fleetwood IG, Steinberg GK (2002) Arteriovenous malformations. Lancet 359(9309):863-873. doi:10.1016/S0140-6736 (02) 07946-1
5. Matsubara S, Mandzia JL, Ter Brugge K, Willinsky RA, Faughnan ME (2000) Angiographic and clinical characteristics of patients with cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia. Am J Neuroradiol 21(6):1016-1020
6. Willemse RB, Mager JJ, Westermann CJ, Overtoom TT, Mauser H, Wolbers JG (2000) Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia. J Neurosurg 92(5):779-784. doi:10.3171/jns.2000.92.5.0779
7. Letteboer TG, Mager JJ, Snijder RJ, Koeleman BP, Lindhout D, Ploos Van Amstel JK, Westermann CJ (2006) Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia. J Med Genet 43(4):371-377. doi:10.1136/jmg.2005. 035451
8. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M (2004) The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18(8):901-911. doi:10.1101/gad.291004
9. Kokubo H, Miyagawa-Tomita S, Johnson RL (2005) Hesr, a mediator of the Notch signaling, functions in heart and vessel development. Trends Cardiovasc Med 15(5):190-194. doi:10.1016/j.tcm.2005.05.005
10. Gridley T (2010) Notch signaling in the vasculature. Curr Top Dev Biol 92:277-309. doi:10.1016/S0070-2153 (10) 92009-7
11. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cecillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser MG, Tournier-Lasserve E (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383(6602):707-710. doi:10.1038/383707a0
12. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, Piccoli DA, Meltzer PS, Spinner NB, Collins FS, Chandrasekharappa SC (1997) Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 16(3):235-242. doi:10.1038/ng0797-235
13. Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, Smith GH, Stark KL, Gridley T (2000) Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 14(11):1343-1352
14. Murphy PA, Lu G, Shiah S, Bollen AW, Wang RA (2009) Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease. Lab Investig 89(9):971-982. doi:10.1038/labinvest.2009.62
15. Zhu Ge Q, Zhong M, Zheng W, Yang GY, Mao X, Xie L, Chen G, Chen Y, Lawton MT, Young WL, Greenberg DA, Jin K (2009) Notch-1 signalling is activated in brain arteriovenous malformations in humans. Brain 132 (Pt 12):3231-3241. doi:10.1093/brain/awp246
16. Krebs LT, Starling C, Chervonsky AV, Gridley T (2010) Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants. Genesis 48(3):146-150. doi:10.1002/dvg.20599
17. Carlson TR, Yan Y, Wu X, Lam MT, Tang GL, Beverly LJ, Messina LM, Capobianco AJ, Werb Z, Wang R (2005) Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci USA 102(28):9884-9889. doi:10.1073/pnas.0504391102
18. Murphy PA, Kim TN, Lu G, Bollen AW, Schaffer CB, Wang RA (2012) Notch4 normalization reduces blood vessel size in arteriovenous malformations. Sci Transl Med 4(117):117ra118. doi:10.1126/scitranslmed.3002670
19. Swiatek PJ, Lindsell CE, Del Amo FF, Weinmaster G, Gridley T (1994) Notch1 is essential for postimplantation development in mice. Genes Dev 8(6):707-719
20. Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA, Weinstein BM (2001) Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128(19):3675-3683
21. Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J (1996) Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development 122(7):2251-2259
22. Uyttendaele H, Ho J, Rossant J, Kitajewski J (2001) Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci USA 98(10):5643-5648. doi:10.1073/pnas.091584598
23. Murphy PA, Lam MT, Wu X, Kim TN, Vartanian SM, Bollen AW, Carlson TR, Wang RA (2008) Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice. Proc Natl Acad Sci USA 105(31):10901-10906. doi:10.1 073/pnas.0802743105
24. Friedlander RM (2007) Clinical practice. Arteriovenous malformations of the brain. N Engl J Med 356(26):2704-2712. doi:10. 1056/NEJMcp067192
25. Duarte A, Hirashima M, Benedito R, Trindade A, Diniz P, Bekman E, Costa L, Henrique D, Rossant J (2004) Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 18(20):2474-2478. doi:10.1101/gad.1239004
26. Gale NW, Dominguez MG, Noguera I, Pan L, Hughes V, Valenzuela DM, Murphy AJ, Adams NC, Lin HC, Holash J, Thurston G, Yancopoulos GD (2004) Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 101(45):15949-15954. doi:10.1073/pnas.0407290101
27. Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T (2004) Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 18(20):2469-2473. doi:10.1101/gad.1239204
28. Hellstrom M, Phng LK, Hofmann JJ, Wallgard E, Coultas L, Lindblom P, Alva J, Nilsson AK, Karlsson L, Gaiano N, Yoon K, Rossant J, Iruela-Arispe ML, Kalen M, Gerhardt H, Betsholtz C (2007) Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 445(7129):776-780. doi:10.1038/nature05571
29. Suchting S, Freitas C, Le Noble F, Benedito R, Breant C, Duarte A, Eichmann A (2007) The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA 104(9):3225-3230. doi:10.1073/p nas.0611177104
30. Lobov IB, Renard RA, Papadopoulos N, Gale NW, Thurston G, Yancopoulos GD, Wiegand SJ (2007) Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 104(9):3219-3224. doi:10.1 073/pnas.0611206104
31. Benedito R, Trindade A, Hirashima M, Henrique D, Da Costa LL, Rossant J, Gill PS, Duarte A (2008) Loss of Notch signalling induced by Dll4 causes arterial calibre reduction by increasing endothelial cell response to angiogenic stimuli. BMC Dev Biol 8:117. doi:10.1186/1471-213X-8-117
32. Trindade A, Kumar SR, Scehnet JS, Lopes-da-Costa L, Becker J, Jiang W, Liu R, Gill PS, Duarte A (2008) Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos. Blood 112(5):1720-1729. doi:10.1182/blood-2007-09-112748
33. Iruela-Arispe ML, Davis GE (2009) Cellular and molecular mechanisms of vascular lumen formation. Dev Cell 16(2):222-231. doi:10.1016/j.devcel.2009.01. 013
34. Moyon D, Pardanaud L, Yuan L, Breant C, Eichmann A (2001) Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development 128(17):3359-3370
35. Carlson TR, Hu H, Braren R, Kim YH, Wang RA (2008) Cellautonomous requirement for beta1 integrin in endothelial cell adhesion, migration and survival during angiogenesis in mice. Development 135(12):2193-2202. doi:10.1242/dev. 016378
36. Park SO, Lee YJ, Seki T, Hong KH, Fliess N, Jiang Z, Park A, Wu X, Kaartinen V, Roman BL, Oh SP (2008) ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2. Blood 111(2):633-642. doi:10.1182/blood-2007-08-107359
37. Kim YH, Hu H, Guevara-Gallardo S, Lam MT, Fong SY, Wang RA (2008) Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis. Development 135(22):3755-3764. doi:10.1242/dev. 022475
38. Deng Y, Larrivee B, Zhuang ZW, Atri D, Moraes F, Prahst C, Eichmann A, Simons M (2013) Endothelial RAF1/ERK activation regulates arterial morphogenesis. Blood 121(19):3988-3996. doi:10.1182/blood-2012-12-474601 (S3981-S3989)
39. Tirziu D, Jaba IM, Yu P, Larrivee B, Coon BG, Cristofaro B, Zhuang ZW, Lanahan AA, Schwartz MA, Eichmann A, Simons M (2012) Endothelial nuclear factor-kappaB-dependent regulation of arteriogenesis and branching. Circulation 126(22):2589-2600. doi:10.1161/CIRCULATIONAHA.112.119321
40. Cristofaro B, Shi Y, Faria M, Suchting S, Leroyer AS, Trindade A, Duarte A, Zovein AC, Iruela-Arispe ML, Nih LR, Kubis N, Henrion D, Loufrani L, Todiras M, Schleifenbaum J, Gollasch M, Zhuang ZW, Simons M, Eichmann A, Le Noble F (2013) Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models. Development 140(8):1720-1729. doi:10.1242/dev. 092304
41. David L, Feige JJ, Bailly S (2009) Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20(3):203-212. doi:10.1016/j.cytogfr.2009.05.001
42. Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, Wrana JL (1993) Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75(4):671-680
43. Kretzschmar M, Liu F, Hata A, Doody J, Massague J (1997) The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 11(8):984-995
44. Nakao A, Roijer E, Imamura T, Souchelnytskyi S, Stenman G, Heldin CH, Ten Dijke P (1997) Identification of Smad2, a human Mad-related protein in the transforming growth factor beta signaling pathway. J Biol Chem 272(5):2896-2900
45. Nomura M, Li E (1998) Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393(6687):786-790. doi:10.1038/31693
46. Yamamoto N, Akiyama S, Katagiri T, Namiki M, Kurokawa T, Suda T (1997) Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts. Biochem Biophys Res Commun 238(2):574-580. doi:10.1006/bbrc. 1997.7325
47. Moustakas A, Heldin CH (2005) Non-Smad TGF-beta signals. J Cell Sci 118 (Pt 16):3573-3584. doi:10.1242/jcs.02554
48. Lagna G, Hata A, Hemmati-Brivanlou A, Massague J (1996) Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 383(6603):832-836. doi:10.1038/383832a0
49. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K (1997) Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389(6651):622-626. doi:10.1038/39355
50. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, Ten Dijke P (1997) Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389(6651):631-635. doi:10.1038/39369
51. Yan X, Liu Z, Chen Y (2009) Regulation of TGF-beta signaling by Smad7. Acta Biochim Biophys Sin (Shanghai) 41(4):263-272
52. Pardali E, Goumans MJ, Ten Dijke P (2010) Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol 20(9):556-567. doi:10.1016/j.tcb.2010.06.006
53. Guo X, Wang XF (2009) Signaling cross-talk between TGFbeta/BMP and other pathways. Cell Res 19(1):71-88. doi:10.1 038/cr.2008.302
54. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, Ten Dijke P, Kim S, Li E (2000) Activin receptorlike kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 97(6):2626-2631
55. Abdalla SA, Letarte M (2006) Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 43(2):97-110. doi:10.1136/jmg.2005.030833
56. Shovlin CL (2010) Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 24(6):203-219. doi:10.1016/j.blre.2010.07.001
57. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 91(1):66-67
58. Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T, Tang W, Miller F, Mao R (2006) A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet Part A 140(20):2155-2162. doi:10. 1002/ajmg.a.31450
59. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J et al (1994) Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet 8(4):345-351. doi:10.1038/ng1294- 345
60. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous ME, Marchuk DA (1996) Mutations in the activin receptorlike kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet 13(2):189-195. doi:10.1038/ng0696-189
61. Cole SG, Begbie ME, Wallace GM, Shovlin CL (2005) A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet 42(7):577-582. doi:10.1136/jmg.2004.028712
62. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk DA (2004) A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363(9412):852-859. doi:10.1016/S0140-6736 (04) 15732-2
63. Gallione CJ, Richards JA, Letteboer TG, Rushlow D, Prigoda NL, Leedom TP, Ganguly A, Castells A, Ploos Van Amstel JK, Westermann CJ, Pyeritz RE, Marchuk DA (2006) SMAD4 mutations found in unselected HHT patients. J Med Genet 43(10):793-797. doi:10.1136/jmg.2006.041517
64. Bourdeau A, Dumont DJ, Letarte M (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Investig 104(10):1343-1351. doi:10.1172/JCI8088
65. Srinivasan S, Hanes MA, Dickens T, Porteous ME, Oh SP, Hale LP, Marchuk DA (2003) A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 12(5):473-482
66. Li F, Lan Y, Wang Y, Wang J, Yang G, Meng F, Han H, Meng A, Wang Y, Yang X (2011) Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev cell 20(3):291-302. doi:10.1016/j.devcel.2011.01.011
67. Seki T, Yun J, Oh SP (2003) Arterial endothelium-specific activin receptor-like kinase 1 expression suggests its role in arterialization and vascular remodeling. Circ Res 93(7):682-689. doi:10.1161/01. RES.0000095246.40391.3B
68. Corti P, Young S, Chen CY, Patrick MJ, Rochon ER, Pekkan K, Roman BL (2011) Interaction between alk1 and blood flow in the development of arteriovenous malformations. Development 138(8):1573-1582. doi:10.1242/dev. 060467
69. Roman BL, Pham VN, Lawson ND, Kulik M, Childs S, Lekven AC, Garrity DM, Moon RT, Fishman MC, Lechleider RJ, Weinstein BM (2002) Disruption of acvrl1 increases endothelial cell number in zebrafish cranial vessels. Development 129(12):3009-3019
70. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, Ten Dijke P (2002) Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J 21(7):1743-1753. doi:10.1093/emboj/21.7.1743
71. David L, Mallet C, Vailhe B, Lamouille S, Feige JJ, Bailly S (2007) Activin receptor-like kinase 1 inhibits human microvascular endothelial cell migration: potential roles for JNK and ERK. J Cell Physiol 213(2):484-489. doi:10.1002/jcp. 21126
72. Scharpfenecker M, Van Dinther M, Liu Z, Van Bezooijen RL, Zhao Q, Pukac L, Lowik CW, Ten Dijke P (2007) BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci 120 (Pt 6):964-972. doi:10.1242/jcs.002949
73. Shao ES, Lin L, Yao Y, Bostrom KI (2009) Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells. Blood 114(10):2197-2206. doi:10.1182/blood-2009-01-199166
74. Urness LD, Sorensen LK, Li DY (2000) Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26(3):328-331. doi:10.1038/81634
75. Park SO, Wankhede M, Lee YJ, Choi EJ, Fliess N, Choe SW, Oh SH, Walter G, Raizada MK, Sorg BS, Oh SP (2009) Realtime imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. J Clin Investig 119(11):3487-3496. doi:10.1172/JCI39482
76. Milton I, Ouyang D, Allen CJ, Yanasak NE, Gossage JR, Alleyne CH Jr, Seki T (2012) Age-dependent lethality in novel transgenic mouse models of central nervous system arteriovenous malformations. Stroke 43(5):1432-1435. doi:10.1161/S TROKEAHA.111.647024
77. Walker EJ, Su H, Shen F, Degos V, Jun. K, Young WL (2012) Bevacizumab attenuates VEGF-induced angiogenesis and vascular malformations in the adult mouse brain. Stroke 43(7):1925-1930. doi:10.1161/STROKEAHA.111.647982
78. Hao Q, Su H, Marchuk DA, Rola R, Wang Y, Liu W, Young WL, Yang GY (2008) Increased tissue perfusion promotes capillary dysplasia in the ALK1-deficient mouse brain following VEGF stimulation. Am J Physiol Heart Circ Physiol 295(6):H2250-H2256. doi:10.1152/ajpheart.00083.2008
79. Hao Q, Zhu Y, Su H, Shen F, Yang GY, Kim H, Young WL (2010) VEGF induces more severe cerebrovascular Dysplasia in Endoglin than in Alk1 mice. Trans Stroke Res 1(3):197-201. doi:10.1007/s12975-010-0020-x
80. Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, Ten Dijke P (2003) Activin receptorlike kinase (ALK) 1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12(4):817-828
81. Goumans MJ, Lebrin F, Valdimarsdottir G (2003) Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med 13(7):301-307
82. David L, Mallet C, Keramidas M, Lamande N, Gasc JM, Dupuis-Girod S, Plauchu H, Feige JJ, Bailly S (2008) Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res 102(8):914-922. doi:10.1161/CIRCRES AHA.107.165530
83. Larrivee B, Prahst C, Gordon E, Del Toro R, Mathivet T, Duarte A, Simons M, Eichmann A (2012) ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev cell 22(3):489-500. doi:10.1016/j.devcel.2012.02.005
84. Park JE, Shao D, Upton PD, Desouza P, Adcock IM, Davies RJ, Morrell NW, Griffiths MJ, Wort SJ (2012) BMP-9 induced endothelial cell tubule formation and inhibition of migration involves Smad1 driven endothelin-1 production. PLoS ONE 7(1):e30075. doi:10.1371/journal.pone.0030075
85. Young K, Conley B, Romero D, Tweedie E, O'Neill C, Pinz I, Brogan L, Lindner V, Liaw L, Vary CP (2012) BMP9 regulates endoglin-dependent chemokine responses in endothelial cells. Blood 120(20):4263-4273. doi:10.1182/blood-2012- 07-440784
86. Ricard N, Ciais D, Levet S, Subileau M, Mallet C, Zimmers TA, Lee SJ, Bidart M, Feige JJ, Bailly S (2012) BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. Blood 119(25):6162-6171. doi:10.1182/blood-2012-01- 407593
87. Berg JN, Guttmacher AE, Marchuk DA, Porteous ME (1996) Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 33(3):256-257
88. Ten Dijke P, Goumans MJ, Pardali E (2008) Endoglin in angiogenesis and vascular diseases. Angiogenesis 11(1):79-89. doi:10.1007/s10456-008-9101-9
89. Ma X, Labinaz M, Goldstein J, Miller H, Keon WJ, Letarte M, O'Brien E (2000) Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration. Arter Thromb Vasc Biol 20(12):2546-2552
90. Jonker L, Arthur HM (2002) Endoglin expression in early development is associated with vasculogenesis and angiogenesis. Mech Dev 110 (1-2):193-196
91. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP (1999) Defective angiogenesis in mice lacking endoglin. Science 284(5419):1534-1537
92. Mahmoud M, Allinson KR, Zhai Z, Oakenfull R, Ghandi P, Adams RH, Fruttiger M, Arthur HM (2010) Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ Res 106(8):1425-1433. doi:10.1161/CIRCRES AHA.109.211037
93. Lebrin F, Srun S, Raymond K, Martin S, Van Den Brink S, Freitas C, Breant C, Mathivet T, Larrivee B, Thomas JL, Arthur HM, Westermann CJ, Disch F, Mager JJ, Snijder RJ, Eichmann A, Mummery CL (2010) Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 16(4):420-428. doi:10.1038/nm.2131
94. Satomi J, Mount RJ, Toporsian M, Paterson AD, Wallace MC, Harrison RV, Letarte M (2003) Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke 34(3):783-789. doi:10.1161/01. STR.0000056170.47815.37
95. Torsney E, Charlton R, Diamond AG, Burn J, Soames JV, Arthur HM (2003) Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality. Circulation 107(12):1653-1657. doi:10.1161/01. CIR.0000058170.92267.00
96. Zhu Y, Sun Y, Xie L, Jin K, Sheibani N, Greenberg DA (2003) Hypoxic induction of endoglin via mitogen-activated protein kinases in mouse brain microvascular endothelial cells. Stroke 34(10):2483-2488. doi:10.1161/01. STR.0000088644.60368. ED
97. Choi EJ, Walker EJ, Shen F, Oh SP, Arthur HM, Young WL, Su H (2012) Minimal homozygous endothelial deletion of eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse. Cerebrovasc Dis 33(6):540-547. doi:10.1159/000337762
98. Matsubara S, Bourdeau A, Ter Brugge KG, Wallace C, Letarte M (2000) Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations. Stroke 31(11):2653-2660
99. Cymerman U, Vera S, Pece-Barbara N, Bourdeau A, White RI Jr, Dunn J, Letarte M (2000) Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatr Res 47(1):24-35
100. Pece N, Vera S, Cymerman U, White RI Jr, Wrana JL, Letarte M (1997) Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Investig 100(10):2568-2579. doi:10.1172/JCI119800
101. Bourdeau A, Cymerman U, Paquet ME, Meschino W, McKinnon WC, Guttmacher AE, Becker L, Letarte M (2000) Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol 156(3):911-923. doi:10.1016/S0002-9440 (10) 64960-7
102. Gallione C, Aylsworth AS, Beis J, Berk T, Bernhardt B, Clark RD, Clericuzio C, Danesino C, Drautz J, Fahl J, Fan Z, Faughnan ME, Ganguly A, Garvie J, Henderson K, Kini U, Leedom T, Ludman M, Lux A, Maisenbacher M, Mazzucco S, Olivieri C, Ploos Van Amstel JK, Prigoda-Lee N, Pyeritz RE, Reardon W, Vandezande K, Waldman JD, White RI Jr, Williams CA, Marchuk DA (2010) Overlapping spectra of SMAD4 mutations in juvenile polyposis (JP) and JP-HHT syndrome. Am J Med Genet Part A 152 A (2):333-339. doi:10.1002/ajmg.a.33206
103. Yao Y, Jumabay M, Wang A, Bostrom KI (2011) Matrix Gla protein deficiency causes arteriovenous malformations in mice. J Clin Investig 121(8):2993-3004. doi:10.1172/JCI57567
104. Bostrom K, Zebboudj AF, Yao Y, Lin TS, Torres A (2004) Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-beta1 activity in endothelial cells. J Biol Chem 279(51):52904-52913. doi:10.1074/jbc. M406868200
105. Yao Y, Zebboudj AF, Shao E, Perez M, Bostrom K (2006) Regulation of bone morphogenetic protein-4 by matrix GLA protein in vascular endothelial cells involves activin-like kinase receptor 1. J Biol Chem 281(45):33921-33930. doi:10.1074/jbc. M604239200
106. Bostrom K, Tsao D, Shen S, Wang Y, Demer LL (2001) Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem 276(17):14044-14052. doi:10.1074/jbc. M008103200
107. Sorensen LK, Brooke BS, Li DY, Urness LD (2003) Loss of distinct arterial and venous boundaries in mice lacking endoglin, a vascular-specific TGFbeta coreceptor. Dev Biol 261(1):235-250
108. Itoh F, Itoh S, Goumans MJ, Valdimarsdottir G, Iso T, Dotto GP, Hamamori Y, Kedes L, Kato M, Ten Dijke Pt P (2004) Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J 23(3):541-551. doi:10.1 038/sj.emboj.7600065
109. Kim JH, Peacock MR, George SC, Hughes CC (2012) BMP9 induces EphrinB2 expression in endothelial cells through an Alk1-BMPRII/ActRII-ID1/ID3-dependent pathway: implications for hereditary hemorrhagic telangiectasia type II. Angiogenesis 15(3):497-509. doi:10.1007/s10456-012-9277-x
110. Moya IM, Umans L, Maas E, Pereira PN, Beets K, Francis A, Sents W, Robertson EJ, Mummery CL, Huylebroeck D, Zwijsen A (2012) Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. Dev Cell 22(3):501-514. doi:10.1016/j.devcel.2012.01.007
111. Somekawa S, Imagawa K, Hayashi H, Sakabe M, Ioka T, Sato GE, Inada K, Iwamoto T, Mori T, Uemura S, Nakagawa O, Saito Y (2012) Tmem100, an ALK1 receptor signalingdependent gene essential for arterial endothelium differentiation and vascular morphogenesis. Proc Natl Acad Sci USA 109(30):12064-12069. doi:10.1073/pnas.1207210109
112. Walker EJ, Su H, Shen F, Choi EJ, Oh SP, Chen G, Lawton MT, Kim H, Chen Y, Chen W, Young WL (2011) Arteriovenous malformation in the adult mouse brain resembling the human disease. Ann Neurol 69(6):954-962. doi:10.1002/ana.22348
113. Kim H, Su H, Weinsheimer S, Pawlikowska L, Young WL (2011) Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm. Acta Neurochir Suppl 111:83-92. doi:10.1007/978-3-7091-0693-8-14
114. Wooderchak-Donahue WL, McDonald J, O'Fallon B, Upton PD, Li W, Roman BL, Young S, Plant P, Fulop GT, Langa C, Morrell NW, Botella LM, Bernabeu C, Stevenson DA, Runo JR, Bayrak-Toydemir P (2013) BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia. Am J Hum Genet. doi:10.1016/j.ajhg.2013.07.004
115. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, D'Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte M, Karumanchi SA (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12(6):642-649. doi:10.1038/nm1429
116. Chen Y, Hao Q, Kim H, Su H, Letarte M, Karumanchi SA, Lawton MT, Barbaro NM, Yang GY, Young WL (2009) Soluble endoglin modulates aberrant cerebral vascular remodeling. Ann Neurol 66(1):19-27. doi:10.1002/ana.21710
117. Li C, Guo B, Ding S, Rius C, Langa C, Kumar P, Bernabeu C, Kumar S (2003) TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1. Anticancer Res 23 (2 B):1189-1196
118. Koizumi T, Shiraishi T, Hagihara N, Tabuchi K, Hayashi T, Kawano T (2002) Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. Neurosurgery 50(1):117-124 (discussion 124-116)
119. Sure U, Butz N, Schlegel J, Siegel AM, Wakat JP, Mennel HD, Bien S, Bertalanffy H (2001) Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg 94(6):972-977. doi:10.3171/jns.2001.94.6.0972
120. Jabbour MN, Elder JB, Samuelson CG, Khashabi S, Hofman FM, Giannotta SL, Liu CY (2009) Aberrant angiogenic characteristics of human brain arteriovenous malformation endothelial cells. Neurosurgery 64(1):139-146. doi:10.1227/01. NEU.0000334417.56742.24 (discussion 146-138)
121. Eerola I, Boon LM, Mulliken JB, Burrows PE, Dompmartin A, Watanabe S, Vanwijck R, Vikkula M (2003) Capillary malformationarteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. Am J Hum Genet 73(6):1240-1249. doi:10.1086/379793
122. Boon LM, Mulliken JB, Vikkula M (2005) RASA1: variable phenotype with capillary and arteriovenous malformations. Curr Opin Genet Dev 15(3):265-269. doi:10.1016/j.gde.2005.03.004
123. Revencu N, Boon LM, Mulliken JB, Enjolras O, Cordisco MR, Burrows PE, Clapuyt P, Hammer F, Dubois J, Baselga E, Brancati F, Carder R, Quintal JM, Dallapiccola B, Fischer G, Frieden IJ, Garzon M, Harper J, Johnson-Patel J, Labreze C, Martorell L, Paltiel HJ, Pohl A, Prendiville J, Quere I, Siegel DH, Valente EM, Van Hagen A, Van Hest L, Vaux KK, Vicente A, Weibel L, Chitayat D, Vikkula M (2008) Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fastflow vascular anomalies are caused by RASA1 mutations. Hum Mutat 29(7):959-965. doi:10.1002/humu.20746
124. Gibbs JB, Marshall MS, Scolnick EM, Dixon RA, Vogel US (1990) Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP). J Biol Chem 265(33):20437-20442
125. Clark GJ, Quilliam LA, Hisaka MM, der CJ (1993) Differential antagonism of Ras biological activity by catalytic and Src homology domains of Ras GTPase activation protein. Proc Natl Acad Sci USA 90(11):4887-4891
126. Henkemeyer M, Rossi DJ, Holmyard DP, Puri MC, Mbamalu G, Harpal K, Shih TS, Jacks T, Pawson T (1995) Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature 377(6551):695-701. doi:10.1038/377695a0
127. Kulkarni SV, Gish G, Van Der Geer P, Henkemeyer M, Pawson T (2000) Role of p120 Ras-GAP in directed cell movement. J Cell Biol 149(2):457-470
128. Chen Y, Pawlikowska L, Yao JS, Shen F, Zhai W, Achrol AS, Lawton MT, Kwok PY, Yang GY, Young WL (2006) Interleukin-6 involvement in brain arteriovenous malformations. Ann Neurol 59(1):72-80. doi:10.1002/ana.20697
129. Chen Y, Zhu W, Bollen AW, Lawton MT, Barbaro NM, Dowd CF, Hashimoto T, Yang GY, Young WL (2008) Evidence of inflammatory cell involvement in brain arteriovenous malformations. Neurosurgery 62(6):1340-1349. doi:10.1227/01. neu.0000333306.64683.b5 (discussion 1349-1350)
130. Storer KP, Tu J, Karunanayaka A, Morgan MK, Stoodley MA (2008) Inflammatory molecule expression in cerebral arteriovenous malformations. J Clin Neurosci 15(2):179-184. doi:10.1016/j.jocn. 2006.10.013
131. Toporsian M, Jerkic M, Zhou YQ, Kabir MG, Yu LX, McIntyre BA, Davis A, Wang YJ, Stewart DJ, Belik J, Husain M, Henkelman M, Letarte M (2010) Spontaneous adult-onset pulmonary arterial hypertension attributable to increased endothelial oxidative stress in a murine model of hereditary hemorrhagic telangiectasia. Arter Thromb Vasc Biol 30(3):509-517. doi:10.1161/A TVBAHA.109.200121
132. Braverman IM, Keh A, Jacobson BS (1990) Ultrastructure and three-dimensional organization of the telangiectases of hereditary hemorrhagic telangiectasia. J Investig Dermatol 95(4):422-427
133. Sammons V, Davidson A, Tu J, Stoodley MA (2011) Endothelial cells in the context of brain arteriovenous malformations. J Clin Neurosci 18(2):165-170.
134. Sato S, Kodama N, Sasaki T, Matsumoto M, Ishikawa T (2004) Perinidal dilated capillary networks in cerebral arteriovenous malformations. Neurosurgery 54(1):163-168 (discussion 168-170)
135. Sure U, Butz N, Siegel AM, Mennel HD, Bien S, Bertalanffy H (2001) Treatment-induced neoangiogenesis in cerebral arteriovenous malformations. Clin Neurol Neurosurg 103(1):29-32
136. Tu J, Stoodley MA, Morgan MK, Storer KP (2006) Ultrastructure of perinidal capillaries in cerebral arteriovenous malformations. Neurosurgery 58(5):961-970. doi:10.1227/01. NEU.0000210248.39504. B5 (discussion 961-970)
137. Carvalho RL, Jonker L, Goumans MJ, Larsson J, Bouwman P, Karlsson S, Dijke PT, Arthur HM, Mummery CL (2004) Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia. Development 131(24):6237-6247. doi:10.1242/dev. 01529
138. Kovacic JC, Mercader N, Torres M, Boehm M, Fuster V (2012) Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease. Circulation 125(14):1795-1808. doi:10.1161/CIRCULATION AHA.111.040352
139. Chen PY, Qin L, Barnes C, Charisse K, Yi T, Zhang X, Ali R, Medina PP, Yu J, Slack FJ, Anderson DG, Kotelianski V, Wang F, Tellides G, Simons M (2012) FGF regulates TGFbeta signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Rep 2(6):1684-1696. doi:10.1016/j. celrep. 2012.10.021
140. Chang AC, Fu Y, Garside VC, Niessen K, Chang L, Fuller M, Setiadi A, Smrz J, Kyle A, Minchinton A, Marra M, Hoodless PA, Karsan A (2011) Notch initiates the endothelial-to-mesenchymal transition in the atrioventricular canal through autocrine activation of soluble guanylyl cyclase. Dev Cell 21(2):288-300. doi:10.1016/j.devcel.2011.06.022
141. Tang Y, Urs S, Boucher J, Bernaiche T, Venkatesh D, Spicer DB, Vary CP, Liaw L (2010) Notch and transforming growth factor-beta (TGFbeta) signaling pathways cooperatively regulate vascular smooth muscle cell differentiation. J Biol Chem 285(23):17556-17563. doi:10.1074/jbc. M109.076414
142. Niessen K, Fu Y, Chang L, Hoodless PA, McFadden D, Karsan A (2008) Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J Cell Biol 182(2):315-325. doi:10.1083/jcb.200710067
143. Zavadil J, Cermak L, Soto-Nieves N, Bottinger EP (2004) Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelialto-mesenchymal transition. EMBO J 23(5):1155-1165. doi:10.1038/sj.emboj.7600069
144. Fu Y, Chang A, Chang L, Niessen K, Eapen S, Setiadi A, Karsan A (2009) Differential regulation of transforming growth factor beta signaling pathways by Notch in human endothelial cells. J Biol Chem 284(29):19452-19462. doi:10.1074/jbc. M109.011833
145. Maddaluno L, Rudini N, Cuttano R, Bravi L, Giampietro C, Corada M, Ferrarini L, Orsenigo F, Papa E, Boulday G, Tournier-Lasserve E, Chapon F, Richichi C, Retta SF, Lampugnani MG, Dejana E (2013) EndMT contributes to the onset and progression of cerebral cavernous malformations. Nature 498(7455):492-496. doi:10.1038/nature12207
146. Kanellopoulou T, Alexopoulou A (2013) Bevacizumab in the treatment of hereditary hemorrhagic telangiectasia. Expert Opin Biol Ther. doi:10.1517/14712598.2013.813478